Stugeron
Controls motion sickness by acting as a non-competitive antagonist of vasoactive agents and selectively inhibiting calcium influx into depolarised vestibular and vascular smooth muscle cells.
- Category
- Neurology
- Active ingredient
- Cinnarizine
- Route
- Oral use
- Form
- Tablet
- Strengths
- 25mg
You will receive a quality generic equivalent of Stugeron, depending on stock.
Prescription and consultation requirements for Stugeron vary by destination and are determined by the fulfilment partner.
Stugeron details
- Condition
- Control of Motion Sickness
- Therapeutic class
- Antivertigo preparations
- Pharmacological class
- Piperazine derivative with antihistamine and calcium channel blocking properties
- Known off-label uses
- vertigo; vestibular disorders; peripheral circulatory disorders
- Contraindications
- hypersensitivity to cinnarizine or any excipients
- Minor side effects
- somnolence; nausea; dyspepsia; weight increased
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Pharmacy medicine (P), available from a pharmacist without a prescription
- Originator
- McNeil Products Ltd
- Storage instructions
- This medicinal product does not require any special storage conditions.
- Drug interactions
- alcohol; CNS depressants; tricyclic antidepressants
Precautions and warnings
may cause epigastric discomfort; taking after meals may diminish gastric irritation; should only be given in Parkinson's disease if advantages outweigh possible risk of aggravating the disease; should be avoided in porphyria; should be used with care in patients with hepatic or renal insufficiency; patients with rare hereditary problems of fructose or galactose intolerance, Lapp lactase deficiency, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine due to lactose and sucrose content; may cause somnolence especially at start of treatment; may prevent positive reaction to dermal reactivity indicators if used within 4 days prior to testing
Moderate side effects
vomiting; abdominal pain upper; hyperhidrosis; lichenoid keratosis; fatigue; headache
Serious side effects
cholestatic jaundice, requires immediate medical attention; extrapyramidal disorder, requires immediate medical attention; parkinsonism, requires immediate medical attention; subacute cutaneous lupus erythematosus, requires immediate medical attention
Patient summary
Controls motion sickness by acting as a non-competitive antagonist of vasoactive agents and selectively inhibiting calcium influx into depolarised vestibular and vascular smooth muscle cells.
Mechanism of action
Stugeron contains the active substance cinnarizine, which belongs to a group of medicines called antihistamines. It works by blocking histamine receptors and reducing the activity of the balance organ in the inner ear. It also relaxes blood vessels. Stugeron is used to control motion sickness (travel sickness) by preventing the overstimulation of the balance mechanism that occurs during travel and causes feelings of nausea, dizziness, and vomiting.
Age restrictions
Not recommended for children under 5 years. Children aged 5 to 12 years: half the adult dose.
Pregnancy and breastfeeding
Safety in human pregnancy has not been established. Animal studies have not demonstrated teratogenic effects. Not advisable to administer during pregnancy. Use is not recommended in nursing mothers.
What you will receive
Stugeron is the originator brand name, made by McNeil Products Ltd. We use it to identify the medicine and are not affiliated with McNeil Products Ltd.
- The fulfilment partner confirms whether the exact brand or an equivalent containing Cinnarizine is offered.
- The offered brand, manufacturer and dispatch location depend on the product, destination and partner warehouse.
- Check the final product details at checkout before confirming an order.